Case Report
Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19
Table 1
Laboratory examinations on admission.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WBC, white cell count; Ht, hematocrit; RBC, red cell count; Hb, hemoglobin; Plt, platelet count; PT, prothrombin time; PT-INR, prothrombin time-international normalized ratio; APTT, activated partial thromboplastin time; FDP, fibrin/fibrinogen degradation products; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cre, creatinine; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γGTP, gamma-glutamyl transpeptidase: ALP, alkaline phosphatase; LDH, lactate dehydrogenase; CK, creatine kinase; CRP, C-reactive protein; PCT, procalcitonin; Glu, glucose; HbA1c, hemoglobin A1c; IgM, immunoglobulin M; IgG, immunoglobulin G; IgA, immunoglobulin A; HBs-Ag, hepatitis B surface antigens; HCV-Ab, hepatitis C antibody; EBV, Epstein–Barr virus; VCA, viral capsid antigen; FAT, fluorescent antibody technique; EBNA, Epstein–Barr virus nuclear antigen; HSV, herpes simplex virus; EIA, enzyme immunoassay; HIV, human immunodeficiency virus; Ag/Ab, antigen/antibody; and CLEIA, chemiluminescent enzyme immunoassay. |